|Mr. Keith Strachan||Co-Founder, Pres, Interim CEO & Director||234.59k||N/A||N/A|
|Mr. Greg Hunter||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Warren Everitt||CEO of Asia Pacific & Director||181.67k||N/A||N/A|
|Mr. Saravan Subramaniam||VP of Operations & Supply Chain||N/A||N/A||N/A|
|Mr. Ahmed Shehata||Gen. Counsel & Head of Corp. Devel.||N/A||N/A||N/A|
|Mr. Brett Moon||VP of Sales||N/A||N/A||N/A|
|Mr. Kirk Binns||Exec. VP of Global Accounts||N/A||N/A||N/A|
|Mr. Nigel Dewsbury||Head of Quality||N/A||N/A||N/A|
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.
MediPharm Labs Corp.’s ISS Governance QualityScore as of July 1, 2021 is 9. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 4; Compensation: 7.